Kodiak Sciences (KOD) Common Equity (2016 - 2026)

Kodiak Sciences has reported Common Equity for 11 years, with the latest figure at $112.1 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 2.99% year-over-year to $112.1 million; the trailing twelve-month figure through Mar 2026 stood at $112.1 million (up 2.99% YoY), and the FY2025 full-year result was $157.4 million, up 4.72% from the prior year.
• Common Equity for Q1 2026 stood at $112.1 million, down from $157.4 million in the prior quarter.
• The five-year high for Common Equity was $597.4 million in Q1 2022, with the low at $23.7 million in Q3 2025.
• Historically, Common Equity has averaged $271.0 million across 5 years, with a median of $241.2 million in 2024.
• The largest YoY upside for Common Equity was 4.72% in 2025 against a maximum downside of 87.22% in 2025.
• Kodiak Sciences' Common Equity stood at $436.2 million in 2022, then tumbled by 39.06% to $265.8 million in 2023, then sank by 43.45% to $150.3 million in 2024, then increased by 4.72% to $157.4 million in 2025, then dropped by 28.77% to $112.1 million in 2026.
• The last three Common Equity figures came in at $112.1 million (Q1 2026), $157.4 million (Q4 2025), and $23.7 million (Q3 2025), per Business Quant data.